Government IntelligenceGovernment Funding
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
National Institutes of Health
Cooperative Agreement from National Institutes of Health. Official source review is required before action.
- Benefit
- Funding amount undisclosed
- Deadline
- Aug 18, 2027
- Audience
- For profit organizations other than small businesses, Small businesses
- Objective OIP Score
- 53/100
2 warningsOfficial public sourceGrants.gov